Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Baylor Research Institute
Baylor Research Institute
Ohio State University Comprehensive Cancer Center
Children's Hospital Medical Center, Cincinnati
Mayo Clinic
Peking University
Brigham and Women's Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baylor Research Institute
Mayo Clinic
Southern Illinois University
New Mexico Cancer Research Alliance
Duke University